These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29050002)

  • 1. Urinary Erythrocyte-Derived miRNAs: Emerging Role in IgA Nephropathy.
    Duan ZY; Cai GY; Li JJ; Bu R; Chen XM
    Kidney Blood Press Res; 2017; 42(4):738-748. PubMed ID: 29050002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of urinary sediment miRNAs as specific biomarkers of IgA nephropathy.
    Duan ZY; Cai GY; Bu R; Lu Y; Hou K; Chen XM
    Sci Rep; 2016 Mar; 6():23498. PubMed ID: 27000966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary sediment miRNAs reflect tubulointerstitial damage and therapeutic response in IgA nephropathy.
    Liang S; Cai GY; Duan ZY; Liu SW; Wu J; Lv Y; Hou K; Li ZX; Zhang XG; Chen XM
    BMC Nephrol; 2017 Feb; 18(1):63. PubMed ID: 28201996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs in IgA nephropathy.
    Yao X; Zhai Y; An H; Gao J; Chen Y; Zhang W; Zhao Z
    Ren Fail; 2021 Dec; 43(1):1298-1310. PubMed ID: 34547971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of urinary exosomal microRNAs in IgA nephropathy.
    Min QH; Chen XM; Zou YQ; Zhang J; Li J; Wang Y; Li SQ; Gao QF; Sun F; Liu J; Xu YM; Lin J; Huang LF; Huang B; Wang XZ
    J Clin Lab Anal; 2018 Feb; 32(2):. PubMed ID: 28383146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary miRNA profile for the diagnosis of IgA nephropathy.
    Szeto CC; Wang G; Ng JK; Kwan BC; Mac-Moune Lai F; Chow KM; Luk CC; Lai KB; Li PK
    BMC Nephrol; 2019 Mar; 20(1):77. PubMed ID: 30832601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of microRNAs in the urinary sediment of patients with IgA nephropathy.
    Wang G; Kwan BC; Lai FM; Chow KM; Kam-Tao Li P; Szeto CC
    Dis Markers; 2010; 28(2):79-86. PubMed ID: 20364043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological features and outcomes of IgA nephropathy with hematuria and/or minimal proteinuria.
    Tan M; Li W; Zou G; Zhang C; Fang J
    Kidney Blood Press Res; 2015; 40(2):200-6. PubMed ID: 25924707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. U6 can be used as a housekeeping gene for urinary sediment miRNA studies of IgA nephropathy.
    Duan ZY; Cai GY; Li JJ; Bu R; Wang N; Yin P; Chen XM
    Sci Rep; 2018 Jul; 8(1):10875. PubMed ID: 30022109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological features and risk factors analysis of IgA nephropathy associated with acute kidney injury.
    Zhang L; Li J; Yang S; Huang N; Zhou Q; Yang Q; Yu X
    Ren Fail; 2016 Jun; 38(5):799-805. PubMed ID: 27050722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary miR-16-5p can be used as a potential marker of endocapillary hypercellularity in IgA nephropathy.
    Zhang M; Duan ZY; Zhang QY; Xu XG; Zhang Y; Wang P; Duan SW; Wu J; Chen XM; Cai GY
    Sci Rep; 2023 Apr; 13(1):6048. PubMed ID: 37055445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of diagnosis of immunoglobulin A nephropathy prior to renal biopsy and correlation with urinary sediment findings and prognostic grading.
    Nakayama K; Ohsawa I; Maeda-Ohtani A; Murakoshi M; Horikoshi S; Tomino Y
    J Clin Lab Anal; 2008; 22(2):114-8. PubMed ID: 18348316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal biopsy findings and clinical indicators of patients with hematuria without overt proteinuria.
    Hoshino Y; Kaga T; Abe Y; Endo M; Wakai S; Tsuchiya K; Nitta K
    Clin Exp Nephrol; 2015 Oct; 19(5):918-24. PubMed ID: 25672293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgA Nephropathy in Children: A Multicenter Study in Poland.
    Mizerska-Wasiak M; Turczyn A; Such A; Cichoń-Kawa K; Małdyk J; Miklaszewska M; Pietrzyk J; Rybi-Szumińska A; Wasilewska A; Firszt-Adamczyk A; Stankiewicz R; Szczepańska M; Bieniaś B; Zajączkowska M; Pukajło-Marczyk A; Zwolińska D; Siniewicz-Luzeńczyk K; Tkaczyk M; Gadomska-Prokop K; Grenda R; Demkow U; Pańczyk-Tomaszewska M
    Adv Exp Med Biol; 2016; 952():75-84. PubMed ID: 27573641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgA nephropathy: clinical features and natural history--a pediatric perspective.
    Hogg RJ
    Am J Kidney Dis; 1988 Nov; 12(5):358-61. PubMed ID: 3055957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy.
    Moon PG; Lee JE; You S; Kim TK; Cho JH; Kim IS; Kwon TH; Kim CD; Park SH; Hwang D; Kim YL; Baek MC
    Proteomics; 2011 Jun; 11(12):2459-75. PubMed ID: 21595033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal expression of trefoil factor 3 mRNA in association with tubulointerstitial fibrosis in IgA nephropathy.
    Tanaka K; Sugiyama H; Yamanari T; Mise K; Morinaga H; Kitagawa M; Onishi A; Ogawa-Akiyama A; Tanabe K; Eguchi J; Ohmoto Y; Shikata K; Wada J
    Nephrology (Carlton); 2018 Sep; 23(9):855-862. PubMed ID: 29987860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of the roles of hematuria and uric acid in defining the prognosis of patients with IgA nephropathy.
    Hogg R
    Pediatr Nephrol; 2022 May; 37(5):947-958. PubMed ID: 33982147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?
    Suzuki H; Allegri L; Suzuki Y; Hall S; Moldoveanu Z; Wyatt RJ; Novak J; Julian BA
    Dis Markers; 2016; 2016():7806438. PubMed ID: 27647947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and implications of isolated microscopic hematuria in asymptomatic Chinese pregnant women.
    Szeto CC; To KF; Lai FM; Chow KM; Tam WH; Chung KY; Leung CB; Lui SF; Li PK; Lau TK
    Nephron Clin Pract; 2007; 105(4):c147-52. PubMed ID: 17259739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.